Global Nicotinic Acid (CAS 59-67-6) Market 2021
In terms of revenue, the global nicotinic acid market is projected to grow at a compound annual growth rate (CAGR) of 6.1% over the analysis period of 2021 to 2027, according to data and analytics company StrategyHelix.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value and volume for nicotinic acid. The global nicotinic acid market is segmented on the basis of application. By application, it is categorized into cosmetics, feed, food & beverages, industrial, and pharmaceuticals.
The report has profiled some of the key players of the market such as Hebei Yanuo Bioscience Co. Ltd., Henan Xinyi Medicine Group Fine Chemical Industry Company Ltd., Jubilant Life Sciences Limited, Koninklijke DSM N.V., Lonza Group AG, Nantong Acetic Acid Chemical Co. Ltd., Tianjin Zhongrui Pharmaceutical Co. Ltd., Vertellus Holdings LLC.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the nicotinic acid market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Application: cosmetics, feed, food & beverages, industrial, and pharmaceuticals
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global nicotinic acid market
Pinpoint growth sectors and trends for investment
Understand what the future of the global nicotinic acid market looks like
Identify the competitive landscape and window of opportunity
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value and volume for nicotinic acid. The global nicotinic acid market is segmented on the basis of application. By application, it is categorized into cosmetics, feed, food & beverages, industrial, and pharmaceuticals.
The report has profiled some of the key players of the market such as Hebei Yanuo Bioscience Co. Ltd., Henan Xinyi Medicine Group Fine Chemical Industry Company Ltd., Jubilant Life Sciences Limited, Koninklijke DSM N.V., Lonza Group AG, Nantong Acetic Acid Chemical Co. Ltd., Tianjin Zhongrui Pharmaceutical Co. Ltd., Vertellus Holdings LLC.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the nicotinic acid market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Application: cosmetics, feed, food & beverages, industrial, and pharmaceuticals
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global nicotinic acid market
Pinpoint growth sectors and trends for investment
Understand what the future of the global nicotinic acid market looks like
Identify the competitive landscape and window of opportunity
1. MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. MARKET DATA & OUTLOOK
3.1 Market Value
3.2 Market Value Forecast
4. NICOTINIC ACID MARKET BY APPLICATION
4.1 Cosmetics
4.2 Feed
4.3 Food & Beverages
4.4 Industrial
4.5 Pharmaceuticals
5. COMPANY PROFILES
5.1 Hebei Yanuo Bioscience Co., Ltd.
5.2 Henan Xinyi Medicine Group Fine Chemical Industry Company Ltd.
5.3 Jubilant Life Sciences Limited
5.4 Koninklijke DSM N.V.
5.5 Lonza Group AG
5.6 Nantong Acetic Acid Chemical Co., Ltd.
5.7 Tianjin Zhongrui Pharmaceutical Co., Ltd.
5.8 Vertellus Holdings LLC
6. APPENDIX
6.1 About StrategyHelix
6.2 Disclaimer
2. RESEARCH METHODOLOGY
3. MARKET DATA & OUTLOOK
3.1 Market Value
3.2 Market Value Forecast
4. NICOTINIC ACID MARKET BY APPLICATION
4.1 Cosmetics
4.2 Feed
4.3 Food & Beverages
4.4 Industrial
4.5 Pharmaceuticals
5. COMPANY PROFILES
5.1 Hebei Yanuo Bioscience Co., Ltd.
5.2 Henan Xinyi Medicine Group Fine Chemical Industry Company Ltd.
5.3 Jubilant Life Sciences Limited
5.4 Koninklijke DSM N.V.
5.5 Lonza Group AG
5.6 Nantong Acetic Acid Chemical Co., Ltd.
5.7 Tianjin Zhongrui Pharmaceutical Co., Ltd.
5.8 Vertellus Holdings LLC
6. APPENDIX
6.1 About StrategyHelix
6.2 Disclaimer
